| 000 | 01120 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250513143418.0 | ||
| 264 | 0 | _c19980713 | |
| 008 | 199807s 0 0 eng d | ||
| 022 | _a0142-2782 | ||
| 024 | 7 |
_a10.1002/(sici)1099-081x(199805)19:4<263::aid-bdd104>3.0.co;2-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGolden, P L | |
| 245 | 0 | 0 |
_aRationale for influx enhancement versus efflux blockade to increase drug exposure to the brain. _h[electronic resource] |
| 260 |
_bBiopharmaceutics & drug disposition _cMay 1998 |
||
| 300 |
_a263-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aBlood-Brain Barrier _xdrug effects |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 | _aMathematical Computing |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 | _aPharmacokinetics |
| 700 | 1 | _aPollack, G M | |
| 773 | 0 |
_tBiopharmaceutics & drug disposition _gvol. 19 _gno. 4 _gp. 263-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/(sici)1099-081x(199805)19:4<263::aid-bdd104>3.0.co;2-4 _zAvailable from publisher's website |
| 999 |
_c9570823 _d9570823 |
||